These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 24837144)

  • 1. Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
    Wang Z; Lai ST; Xie L; Zhao JD; Ma NY; Zhu J; Ren ZG; Jiang GL
    Diabetes Res Clin Pract; 2014 Oct; 106(1):19-26. PubMed ID: 24837144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis.
    Nie Z; Zhu H; Gu M
    Pharm Biol; 2016 Nov; 54(11):2636-2642. PubMed ID: 27159666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis.
    Zhang H; Gao C; Fang L; Zhao HC; Yao SK
    Scand J Gastroenterol; 2013 Jan; 48(1):78-87. PubMed ID: 23137049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis.
    Zhou PT; Li B; Liu FR; Zhang MC; Wang Q; Li YY; Xu C; Liu YH; Yao Y; Li D
    Oncotarget; 2017 Apr; 8(15):25242-25250. PubMed ID: 28445955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colon neoplasia in patients with type 2 diabetes on metformin: A meta-analysis.
    Rokkas T; Portincasa P
    Eur J Intern Med; 2016 Sep; 33():60-6. PubMed ID: 27318643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between the use of metformin and the risk of pancreatic cancer in patients with diabetes: a systematic review and meta-analysis.
    Hu J; Fan HD; Gong JP; Mao QS
    BMC Gastroenterol; 2023 Feb; 23(1):50. PubMed ID: 36829129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin Use and Lung Cancer Risk in Diabetic Patients: A Systematic Review and Meta-Analysis.
    Yao L; Liu M; Huang Y; Wu K; Huang X; Zhao Y; He W; Zhang R
    Dis Markers; 2019; 2019():6230162. PubMed ID: 30881522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-diabetic medications do not influence risk of lung cancer in patients with diabetes mellitus: a systematic review and meta-analysis.
    Nie SP; Chen H; Zhuang MQ; Lu M
    Asian Pac J Cancer Prev; 2014; 15(16):6863-9. PubMed ID: 25169538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin may improve the prognosis of patients with pancreatic cancer.
    Zhang JW; Sun Q
    Asian Pac J Cancer Prev; 2015; 16(9):3937-40. PubMed ID: 25987064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies.
    Thakkar B; Aronis KN; Vamvini MT; Shields K; Mantzoros CS
    Metabolism; 2013 Jul; 62(7):922-34. PubMed ID: 23419783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin and breast cancer risk: a meta-analysis and critical literature review.
    Col NF; Ochs L; Springmann V; Aragaki AK; Chlebowski RT
    Breast Cancer Res Treat; 2012 Oct; 135(3):639-46. PubMed ID: 22847511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis.
    Zhang ZJ; Zheng ZJ; Kan H; Song Y; Cui W; Zhao G; Kip KE
    Diabetes Care; 2011 Oct; 34(10):2323-8. PubMed ID: 21949223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis.
    Meng F; Song L; Wang W
    J Diabetes Res; 2017; 2017():5063239. PubMed ID: 28271076
    [No Abstract]   [Full Text] [Related]  

  • 14. Metformin use and prostate cancer risk: A meta-analysis of cohort studies.
    Feng Z; Zhou X; Liu N; Wang J; Chen X; Xu X
    Medicine (Baltimore); 2019 Mar; 98(12):e14955. PubMed ID: 30896668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of metformin use with fracture risk in type 2 diabetes: A systematic review and meta-analysis of observational studies.
    Wang Y; Yu L; Ye Z; Lin R; Sun AR; Liu L; Wei J; Deng F; Zhong X; Cui L; Li L; Liu Y
    Front Endocrinol (Lausanne); 2022; 13():1038603. PubMed ID: 36714564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis.
    Soranna D; Scotti L; Zambon A; Bosetti C; Grassi G; Catapano A; La Vecchia C; Mancia G; Corrao G
    Oncologist; 2012; 17(6):813-22. PubMed ID: 22643536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis.
    He XK; Su TT; Si JM; Sun LM
    Medicine (Baltimore); 2016 Feb; 95(7):e2749. PubMed ID: 26886616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Metformin with Breast Cancer Incidence and Mortality in Patients with Type II Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis.
    Tang GH; Satkunam M; Pond GR; Steinberg GR; Blandino G; Schünemann HJ; Muti P
    Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):627-635. PubMed ID: 29618465
    [No Abstract]   [Full Text] [Related]  

  • 19. Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and meta-analysis.
    Zhang ZJ; Zheng ZJ; Shi R; Su Q; Jiang Q; Kip KE
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2347-53. PubMed ID: 22523334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between pancreatic cancer and metformin use in patients with type 2 diabetes.
    Lai SW; Tsai CH; Lin CL; Liao KF
    Postgrad Med J; 2019 May; 95(1123):291. PubMed ID: 30975725
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.